Why AI Can’t Automate Science, According to a Philosopher

Why It Matters

The debate highlights that AI will augment, not replace, scientific discovery, preserving the need for human expertise and oversight. Policymakers and investors must calibrate expectations to avoid over‑reliance on automated research.

Key Takeaways

• AI scientists rely on human‑curated datasets, not direct reality.
• Commonsense reasoning gaps cause unrealistic experimental suggestions.
• AlphaFold accelerates analysis but does not create new knowledge.
• Genesis Mission aims to automate hypothesis testing via AI agents.
• Human oversight remains essential for scientific validity and insight.

Pulse Analysis

The rise of artificial intelligence in research has moved from niche applications to sweeping government initiatives, exemplified by the Genesis Mission announced in late 2025. By aggregating federal scientific datasets, the program aims to create autonomous AI agents capable of formulating hypotheses, streamlining experimental design, and accelerating breakthroughs across disciplines. This ambition mirrors private‑sector trends where AI models are deployed to mine literature, predict material properties, or optimize clinical trials, promising faster cycles of innovation while raising expectations about the future of scientific work.

Philosophers and scholars caution that these expectations overlook fundamental limits of current AI. Machine learning systems learn exclusively from data curated by human scientists; they lack direct interaction with the physical world and the commonsense reasoning that guides experimental intuition. Consequently, AI may propose elegant but infeasible experiments, misinterpret causal relationships, or overlook ethical considerations. The critique underscores that scientific progress is not merely pattern recognition but a creative, iterative process involving hypothesis generation, critical evaluation, and contextual judgment—abilities that remain uniquely human.

In practice, AI tools like AlphaFold demonstrate how computational models can transform specific tasks, such as predicting protein structures, thereby expediting drug discovery and disease research. However, AlphaFold does not generate novel biological concepts; it refines existing knowledge. The broader lesson for industry and policymakers is to view AI as a powerful augmentative instrument rather than a replacement for scientists. Investing in hybrid workflows that combine AI’s speed with human expertise will likely yield the most reliable and ethically sound scientific advances, ensuring that automation enhances rather than undermines the integrity of research.